A prospective study to monitor the side effects associated with disease modifying anti rheumatoid drugs in out-patients of tertiary care hospital. Int. J. of Res. in Pharmacology &Pharmacotherapeutics . 2023;12(1):1-7. doi:10.61096/ijrpp.v12.iss1.2023.1-7